Camp4 Therapeutics (CAMP) Operating Income (2023 - 2026)
Camp4 Therapeutics (CAMP) reported Operating Income of -$13.1 million for Q1 2026, little changed on a YoY basis from -$13.0 million in Q1 2025, and down 2.31% sequentially from -$12.8 million in Q4 2025.
Camp4 Therapeutics (CAMP) Operating Income (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of Operating Income data on file, last reported at -$13.1 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income changed 0.22% year-over-year to -$13.1 million; the trailing twelve-month figure through Mar 2026 stood at -$52.5 million (up 1.47% YoY), and the FY2025 full-year result was -$52.6 million, up 1.0% from the prior year.
- Operating Income slipped to -$13.1 million in Q1 2026, from -$12.8 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$12.3 million in Q3 2023 to a low of -$14.0 million in Q4 2024.
- A 4-year average of -$13.1 million and a median of -$13.1 million in 2026 frame the typical range for Operating Income.
- Across the five-year window, Operating Income dropped 9.55% in 2024 and advanced 8.96% in 2025, its largest moves.
- Tracing CAMP's Operating Income over 4 years: stood at -$13.5 million in 2023, then declined by 4.14% to -$14.0 million in 2024, then advanced by 8.96% to -$12.8 million in 2025, then retreated by 2.31% to -$13.1 million in 2026.
- Business Quant data shows CAMP's Operating Income at -$13.1 million in Q1 2026, -$12.8 million in Q4 2025, and -$13.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | -13.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.07 Mn |
| Dec 31, 2025 | -12.78 Mn |
| Sep 30, 2025 | -13.65 Mn |
| Jun 30, 2025 | -13.03 Mn |
| Mar 31, 2025 | -13.10 Mn |
| Dec 31, 2024 | -14.03 Mn |
| Sep 30, 2024 | -13.52 Mn |
| Jun 30, 2024 | -12.66 Mn |
| Mar 31, 2024 | -12.88 Mn |
| Dec 31, 2023 | -13.48 Mn |
| Sep 30, 2023 | -12.34 Mn |